Skip to content

The International Journal of Neuropsychopharmacology

ISSN 1461-1457, 1469-5111

260 papers in the library · 7,343 citations · publishing 2002-2026

Papers

Sort Most recent Most cited

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy").

The International Journal of Neuropsychopharmacology April 1, 2018 Michael D. Wunderli, Matthias Vonmoos, Lorena Treichler et al.

The empathogen 3,4-methylenedioxymethamphetamine (MDMA) is the prototypical prosocial club drug inducing emotional openness to others. It has recently been shown that acutely applied 3,4-MDMA in fact enhances emotional empathy and prosocial behavior, while it simultaneously decreases cognitive empathy. However, the long-term effects of 3,4-MDMA use on socio-cognitive functions and social...

Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects

The International Journal of Neuropsychopharmacology January 13, 2018 J. Donello, P. Banerjee, Yong-Xin Li et al.

Abstract Background Modulation of glutamatergic synaptic transmission by N-methyl-D-aspartate receptors can produce rapid and sustained antidepressant effects. Rapastinel (GLYX-13), initially described as a N-methyl-D-aspartate receptor partial glycine site agonist, exhibits rapid antidepressant effect in rodents without the accompanying dissociative effects of N-methyl-D-aspartate receptor...

Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as Usual in Patients with Depression, Anxiety, or Stress and Adjustment Disorders

The International Journal of Neuropsychopharmacology January 10, 2018 Xiao Wang, Kristina Sundquist, Karolina Palmér et al. 26 citations

Background: Macrophage migration inhibitory factor is a proinflammatory cytokine that has been associated with various psychiatric disorders. MicroRNA-451a can directly target macrophage migration inhibitory factor and downregulate its expression in cells. However, the role of macrophage migration inhibitory factor and microRNA-451a in psychiatric patients treated with psychotherapeutic...

Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?

The International Journal of Neuropsychopharmacology December 23, 2017 Shigeyuki Chaki 17 citations

Major depressive disorder (MDD) affects approximately 10% to 20% of the US population (Kessler et al. , 2005); thus, the economic burden of MDD is immense. Currently, selective serotonin reuptake inhibitors and serotonin- and noradrenaline-reuptake inhibitors are widely prescribed for patients with MDD as first-line treatments. However, these medications have several drawbacks; approximately...

Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine

The International Journal of Neuropsychopharmacology December 22, 2017 K. Fukumoto, M. Iijima, Takeo Funakoshi et al.

Abstract Background We previously reported that serotonergic transmission plays an important role in antidepressant effects of ketamine. However, detailed mechanisms have not been elucidated. Among the serotonin receptor subtypes, the serotonin1A receptor in the medial prefrontal cortex has an important role in depression. Here, we investigated the role of the medial prefrontal cortex...

Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing

The International Journal of Neuropsychopharmacology November 22, 2017 André Schmidt, Felix Müller, Patrick C. Dolder et al. 25 citations

Background: Stimulants such as methylphenidate and modafinil are frequently used as cognitive enhancers in healthy people, whereas 3,4-methylenedioxymethamphetamine (ecstasy) is proposed to enhance mood and empathy in healthy subjects. However, comparative data on the effects of methylphenidate and modafinil on negative emotions in healthy subjects have been partially missing. The aim of this...

DOI: 10.1093/ijnp/pyx112 (opens in new tab) Full text (opens in new tab) MDMA Modafinil Methylphenidate Dextroamphetamine +1

5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model

The International Journal of Neuropsychopharmacology November 15, 2017 Kai Zhang, Chao Dong, Yuko Fujita et al. 48 citations

Background: Previous reports suggest that 5-hydroxytryptamine might play a role in the antidepressant actions of (R,S)-ketamine. However, its role in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, is unknown. This study was conducted to examine whether 5-hydroxytryptamine depletion affects the antidepressant actions of (R)-ketamine in a chronic social defeat...

Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine

The International Journal of Neuropsychopharmacology November 14, 2017 Yukihiko Shirayama, Kenji Hashimoto 113 citations

Background: (R)-Ketamine exhibits rapid and sustained antidepressant effects in animal models of depression. It is stereoselectively metabolized to (R)-norketamine and subsequently to (2R,6R)-hydroxynorketamine in the liver. The metabolism of ketamine to hydroxynorketamine was recently demonstrated to be essential for ketamine's antidepressant actions. However, no study has compared the...

DOI: 10.1093/ijnp/pyx108 (opens in new tab) Full text (opens in new tab) Ketamine Learned helplessness Antidepressant Pharmacology +4

Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion

The International Journal of Neuropsychopharmacology August 30, 2017 Tom P. Freeman, Rebecca Pope, Matthew B. Wall et al. 67 citations

Background: Despite the current shift towards permissive cannabis policies, few studies have investigated the pleasurable effects users seek. Here, we investigate the effects of cannabis on listening to music, a rewarding activity that frequently occurs in the context of recreational cannabis use. We additionally tested how these effects are influenced by cannabidiol, which may offset...

Ultra-Brief Mindfulness Training Reduces Alcohol Consumption in At-Risk Drinkers: A Randomized Double-Blind Active-Controlled Experiment

The International Journal of Neuropsychopharmacology July 28, 2017 Sunjeev K. Kamboj, Damla Irez, Shirley Serfaty et al. 44 citations

Background: Like other complex psychosocial interventions, mindfulness-based treatments comprise various modality-specific components as well as nonspecific therapeutic ingredients that collectively contribute to efficacy. Consequently, the isolated effects of mindfulness strategies per se remain unclear. Methods: Using a randomized double-blind design, we compared the isolated effects of...

Effect of Psilocybin on Empathy and Moral Decision-Making

The International Journal of Neuropsychopharmacology June 14, 2017 Thomas Pokorny, Katrin H. Preller, Michael Kometer et al. 202 citations

Background: Impaired empathic abilities lead to severe negative social consequences and influence the development and treatment of several psychiatric disorders. Furthermore, empathy has been shown to play a crucial role in moral and prosocial behavior. Although the serotonin system has been implicated in modulating empathy and moral behavior, the relative contribution of the various serotonin...

Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities

The International Journal of Neuropsychopharmacology May 17, 2017 Frederic Sampedro, Mario de la Fuente Revenga, Marta Valle et al. 205 citations

Background: Ayahuasca is a plant tea containing the psychedelic 5-HT2A agonist N,N-dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. Post-acutely, ayahuasca potentiates mindfulness capacities in volunteers and induces rapid and...

Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects

The International Journal of Neuropsychopharmacology May 16, 2017 André Schmidt, Felix Müller, Patrick C. Dolder et al. 41 citations

Background: Psychostimulants such as methylphenidate and modafinil are increasingly used by healthy people for cognitive enhancement purposes, whereas the acute effect of 3,4-methylenedioxymethamphetamine (ecstasy) on cognitive functioning in healthy subjects remains unclear. This study directly compared the acute effects of methylphenidate, modafinil, and 3,4-methylenedioxymethamphetamine on...

DOI: 10.1093/ijnp/pyx037 (opens in new tab) Full text (opens in new tab) MDMA Modafinil Methylphenidate Response inhibition +2

The Subjective Response to Nitrous Oxide is a Potential Pharmaco-Endophenotype for Alcohol Use Disorder: A Preliminary Study with Heavy Drinkers.

The International Journal of Neuropsychopharmacology April 1, 2017 Katie Walsh, Ravi Das, Sunjeev K. Kamboj

Healthy people with a family history of alcohol problems show a pattern of subjective responses to alcohol that resemble those of affected probands. Studies on ketamine suggest that up-regulation of N-methyl-D-aspartate receptors (NMDARs) underlies these effects, and point to a pharmacologically-responsive endophenotype reflecting enhanced risk for alcohol-use disorders. Subjective stimulant...

5-HT2A Agonists: A Novel Therapy for Functional Neurological Disorders?

The International Journal of Neuropsychopharmacology February 8, 2017 Alexander Bryson, Olivia Carter, Trevor R. Norman et al. 19 citations

Functional neurological disorders are frequently encountered in clinical practice. They have a poor prognosis and treatment options are limited. Their etiology is unknown, but leading theories propose a disturbance of somatic self-representation: the mind perceives dysfunction of a body region despite intact motor and sensory pathways. Central to this model is the concept of an abnormal...

DOI: 10.1093/ijnp/pyx011 (opens in new tab) Full text (opens in new tab) Cognition Genetic neurodegenerative diseases

S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression

The International Journal of Neuropsychopharmacology November 2, 2016 Maryam Ardalan, Gregers Wegener, Ali H. Rafati et al. 38 citations

Background: The neurovascular plasticity of hippocampus is an important theory underlying major depression. Ketamine as a novel glutamatergic antidepressant drug can induce a rapid antidepressant effect within hours. In a mechanistic proof of this concept, we examined whether ketamine leads to an increase in synaptogenesis and vascularization within 24 hours after a single injection in a...

Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.

The International Journal of Neuropsychopharmacology November 2016 Philip Lr Gaskin, Maria Toledo-Rodriguez, Stephen Ph Alexander et al.

Dysfunction of dopaminergic, GABAergic, and glutamatergic function underlies many core symptoms of schizophrenia. Combined neonatal injection of the N-methyl-D-aspartate (NMDA) receptor antagonist, phencyclidine (PCP), and post-weaning social isolation of rats produces a behavioral syndrome with translational relevance to several core symptoms of schizophrenia. This study uses DNA microarray to...

DOI: 10.1093/ijnp/pyw062 (opens in new tab) Full text (opens in new tab) Glutamate Isolation rearing Lamotrigine Microarray +2

Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine

The International Journal of Neuropsychopharmacology October 7, 2016 Chao Dong, Ji-Chun Zhang, Wei Yao et al. 116 citations

Background: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor antagonist, MGS0039, shows antidepressant effects. However, there are no reports comparing these 2 compounds in the social defeat stress model of depression. Methods: We examined the effects of MGS0039 (1 mg/kg) and ketamine (10 mg/kg) on depression-like behavior in susceptible...

DOI: 10.1093/ijnp/pyw089 (opens in new tab) Ketamine Dentate gyrus Prefrontal cortex Brain-derived neurotrophic factor +9

PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG

The International Journal of Neuropsychopharmacology May 27, 2016 Filip Tylš, Michaela Viktorinová, Dominika Prokopcova et al. 10 citations

Objective: Schizophrenia patients have a higher prevalence of type 2 diabetes mellitus than the general population, and even first-episode, drug-naive (FEDN) patients with schizophrenia have shown a higher prevalence of impaired glucose tolerance (IGT) than the general population.We aimed to investigate the prevalence of abnormal glucose tolerance after glucose loading, and to examine the...

PM504. Theory of Mind in Clinical high risk as trait marker of conversion to psychosis: review

The International Journal of Neuropsychopharmacology May 27, 2016 Jee-Hyung Suh, Tae Young Lee, Jun Soo Kwon 1 citation

Psilocybin, a classical tryptamine hallucinogen, serves as a model of acute psychosis in humans.Intoxication with this compound induces significant alterations in perception, thought disturbance and emotional processing, effects that mimic psychotic symptoms.The neurochemical basis of its effects is related to the stimulation of serotonin 5-HT 1A a 5-HT 2A/C receptors.Disconnection is one of...

DOI: 10.1093/ijnp/pyw041.504 (opens in new tab) Full text (opens in new tab) Psychosis Trait Cognitive psychology Clinical psychology

Speaker 3: Christina Kurre Olsen, Denmark

The International Journal of Neuropsychopharmacology May 27, 2016

Background: Esketamine and ketamine have been shown to produce rapid antidepressant action in patients with treatmentresistant depression (TRD).The aim of the current study was to assess the efficacy, safety and dose response of intranasal esketamine in patients with TRD.Methods: This was a 2-Panel, doubly-randomized, double-blind, placebo-controlled, multicenter study.Panel A was conducted in...

PM505. Impaired glucose tolerance, symptoms and cognitive deficits in first-episode drug-naïve patients with schizophrenia

The International Journal of Neuropsychopharmacology May 27, 2016 Xiangyang Zhang, Dachun Chen, Raymond J. Cho et al.

Psilocybin, a classical tryptamine hallucinogen, serves as a model of acute psychosis in humans.Intoxication with this compound induces significant alterations in perception, thought disturbance and emotional processing, effects that mimic psychotic symptoms.The neurochemical basis of its effects is related to the stimulation of serotonin 5-HT 1A a 5-HT 2A/C receptors.Disconnection is one of...

DOI: 10.1093/ijnp/pyw041.505 (opens in new tab) Full text (opens in new tab) Drug-naïve Schizophrenia object-oriented programming Cognition Clinical psychology

Speaker 2: Jaskaran Singh, USA

The International Journal of Neuropsychopharmacology May 27, 2016 C. Olsen

Background: Esketamine and ketamine have been shown to produce rapid antidepressant action in patients with treatmentresistant depression (TRD). The aim of the current study was to assess the efficacy, safety and dose response of intranasal esketamine in patients with TRD. Methods: This was a 2-Panel, doubly-randomized, double-blind, placebo-controlled, multicenter study. Panel A was conducted...

PS125. Functional and morphological changes induced by ketamine in the hippocampus

The International Journal of Neuropsychopharmacology May 27, 2016 G. Treccani, Liebenberg N. Nico, S. Tillmann et al.

Specific objective of the study: This study is aimed to investigate desipramine, venlafaxine and bupropion on depression and anxiety in mice. Methods used: We used a classic tricyclic antidepressant, desipramine; a serotonin-norepinephrine reuptake inhibitör, venlafaxine; a second-generation antidepressant agent that blocks centrally the reuptake of noradrenaline and dopamine, bupropion in...

PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3ß-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy

The International Journal of Neuropsychopharmacology May 27, 2016 P. Jack, B. Massimiliano, Grazia di Capua et al.

Abstract Objective: One third of major depressive disorder (MDD) patients are unresponsive to antidepressant drugs, a sub-type known as treatment resistant depression (TRD). Acute intravenous administration of ketamine at sub-anaesthetic dosage is the only efficacious pharmacological treatment in TRD. Development of TRD preclinical assays to screen for more efficacious antidepressant drugs and...